MedDRA version: 14.0 Level: LLT Classification code 10051971 Term: Pancreatic adenocarcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Conditions
Interventions
Trade Name: GEMZAR
Pharmaceutical Form: Solution for infusion
INN or Proposed INN: GEMCITABINE
CAS Number: 95058-81-4
Concentration unit: mg milligram(s)
Concentration type: range
Concentration number
Sponsors
Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: ;Secondary Objective: ;Primary end point(s): | — |
Countries
France
Contacts
Public ContactBéata JUZYNA - Chef de Projet
FNCLCC
Outcome results
None listed